🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2, multicenter, open-label study to evaluate the efficacy o...
Status
Suspended
Location
UCSD Moores Cancer Center
Start Date
2025-09
Trial ID
NCT05361915
Treatments Being Tested
The purpose of this study is to investigate Pharmacokinetics parameters of ...
Status
Completed
Location
Jiangsu Province Hospital
Start Date
2016-11
Trial ID
NCT03001609
Treatments Being Tested
The study is a single-arm, multi-center, open-label clinical trial. The stu...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-05-18
Trial ID
NCT03300115
Treatments Being Tested
AC0010 Maleate Capsules is a new, irreversible, Epidermal Growth Factor Rec...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2014-09
Trial ID
NCT02274337
Treatments Being Tested
Study to assess the safety and efficacy of STI-5656 (Abivertinib Maleate) p...
Status
Completed
Location
MedStar Washington Hospital Center
Start Date
2020-10-09
Trial ID
NCT04440007
Treatments Being Tested
This phase II, umbrella trial study directed by next generation sequencing ...
Status
Unknown
Location
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology
Start Date
2018-07-09
Trial ID
NCT03574402
AC0010MA is a new, irreversible, Epidermal Growth Factor Receptor (EGFR) mu...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2015-05
Trial ID
NCT02448251
Treatments Being Tested
A phase 2, placebo-controlled study of the safety and efficacy of STI-5656 ...
Status
Completed
Location
Hospital e Maternidade Christovão da Gama
Start Date
2021-01-06
Trial ID
NCT04528667
A Phase III, Open-Label, Randomized Multicenter Study to Compare AC0010 and...
Status
Withdrawn
Location
Beijing Cancer Hospital
Start Date
2018-12
Trial ID
NCT03058094
Treatments Being Tested
To compare efficacy and safety of Abivertinib maleate alone versus standard...
Status
Unknown
Location
Guangdong Provicial People's Hospital
Start Date
2019-03
Trial ID
NCT03856697